Neutrophil-to-Lymphocyte Ratio and Early Variation of NLR to Predict In-Hospital Mortality and Severity in ED Patients with SARS-CoV-2 Infection.

COVID-19 NLR mortality severity

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
09 Jun 2021
Historique:
received: 01 04 2021
revised: 22 05 2021
accepted: 04 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

(1) Introduction: The neutrophil-to lymphocyte ratio is valued as a predictive marker in several inflammatory diseases. For example, an increasing NLR is a risk factor of mortality in sepsis. It also appears to be helpful in other settings such as cancer. The aim of our work was to study the prognostic value of NLR for disease severity and mortality in patients infected with SARS-CoV-2 upon their admission to the Emergency Department (ED) and its early variation (ΔNLR) in the first 24 h of management (H-24). (2) Methods: Between 1 March and 30 April 2020, we conducted a multicenter and retrospective cohort study of patients with moderate or severe coronavirus disease 19 (COVID-19), who were all hospitalized after presenting to the ED. (3) Results: A total of 1035 patients were included in our study. Factors associated with infection severity were C-reactive protein level (OR: 1.007, CI 95%: [1.005-1.010],

Identifiants

pubmed: 34207918
pii: jcm10122563
doi: 10.3390/jcm10122563
pmc: PMC8229672
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Crit Care. 2015 Jan 19;19:13
pubmed: 25598149
Crit Care. 2015 Dec 16;19:439
pubmed: 26671018
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
J Clin Med Res. 2020 Jul;12(7):448-453
pubmed: 32655740
JAMA Netw Open. 2021 Jan 4;4(1):e2034266
pubmed: 33464319
Epidemiol Infect. 2020 Jul 09;148:e139
pubmed: 32641174
Int Immunopharmacol. 2020 Jul;84:106504
pubmed: 32304994
Int J Antimicrob Agents. 2020 Aug;56(2):106017
pubmed: 32437920
Intern Emerg Med. 2021 Jan 26;:
pubmed: 33496923
Aging (Albany NY). 2020 Jul 30;12(14):13849-13859
pubmed: 32730223
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Front Physiol. 2018 Feb 20;9:113
pubmed: 29515456
Nat Rev Immunol. 2020 Sep;20(9):515-516
pubmed: 32728221
Am J Emerg Med. 2017 Feb;35(2):234-239
pubmed: 27806894
Eur Respir Rev. 2018 Feb 7;27(147):
pubmed: 29436405
Thromb Res. 2020 Aug;192:3-8
pubmed: 32407937
PLoS One. 2012;7(10):e46561
pubmed: 23049706
Ann Transl Med. 2020 May;8(10):635
pubmed: 32566572
Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30
pubmed: 23602134
Am J Emerg Med. 2020 Mar;38(3):641-647
pubmed: 31785981
Crit Care. 2020 Nov 16;24(1):647
pubmed: 33198786
Crit Care. 2010;14(5):R192
pubmed: 21034463
J Am Geriatr Soc. 2017 Aug;65(8):1796-1801
pubmed: 28407209
Cell Metab. 2021 Feb 2;33(2):258-269.e3
pubmed: 33421384

Auteurs

Laure Abensur Vuillaume (L)

Emergency Department, Regional Hospital of Metz-Thionville, 57000 Metz, France.

Pierrick Le Borgne (P)

Emergency Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative NanoMedicine (RNM), Fédération de Médecine Translationnelle (FMTS), University of Strasbourg, 67000 Strasbourg, France.

Karine Alamé (K)

Emergency Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

François Lefebvre (F)

Department of Public Health, University Hospital of Strasbourg, 67000 Strasbourg, France.

Lise Bérard (L)

Emergency Department, Haguenau Hospital, 67500 Haguenau, France.

Nicolas Delmas (N)

Emergency Department, Colmar Hospital, 68000 Colmar, France.

Lauriane Cipolat (L)

Emergency Department, Regional Hospital of Metz-Thionville, 57000 Metz, France.

Stéphane Gennai (S)

Emergency Department, Reims University Hospital, 51000 Reims, France.

Pascal Bilbault (P)

Emergency Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative NanoMedicine (RNM), Fédération de Médecine Translationnelle (FMTS), University of Strasbourg, 67000 Strasbourg, France.

Charles-Eric Lavoignet (CE)

Emergency Department, Hôpital Nord Franche Comté, 90400 Trévenans, France.

Classifications MeSH